Kenny Gardner Named Chief People Officer at DaVita Kidney Care

DaVita Kidney Care recently announced Kenny Gardner as its new chief people officer (CPO). Kenny Gardner has been with DaVita for nearly a decade and most recently served the company as a group vice president (GVP), overseeing field operations in the Southeast U.S.

“Our teams of professionals give life to our patients, day in and day out. It is critical that we provide an environment for both our teammates and our patients to thrive,” said Javier Rodriguez, CEO of DaVita Inc. “I am confident that Kenny’s track record and proven leadership will take us to the next frontier.”

Gardner has held numerous roles since joining DaVita in 2011 as a regional operations director. He has been an executive sponsor of DaVita’s renowned Redwoods recruiting program and a facilitator for DaVita University, which is DaVita’s in-house personal and professional development program. In his latest role as GVP, he also led DaVita’s diagnostic laboratory along with a specialized, cross-functional team tasked with supporting DaVita teammates through innovative technology and tools.

“DaVita is a special place to work where everyone can belong,” said Gardner. “I am honored and excited to be CPO and look forward to this expanded responsibility to serve our thousands of teammates around the world.”

Prior to joining DaVita, Gardner worked as an investment banker for Morgan Stanley, where he focused on mergers and acquisitions. He holds a Bachelor of Science from Florida A&M University, along with a Master of Business Administration from Stanford.

In his free time, Gardner enjoys spending time with his family, giving back to his community, fitness, travel, reading and sports.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”